Published in Front Aging Neurosci on March 24, 2017
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
Loss of recent memory after bilateral hippocampal lesions. J Neurol Neurosurg Psychiatry (1957) 18.90
Place navigation impaired in rats with hippocampal lesions. Nature (1982) 15.79
Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron (2003) 14.03
Alzheimer's disease. Lancet (2006) 9.15
Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science (2007) 8.56
Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging (1995) 6.86
Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron (2007) 6.60
Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron (2005) 6.20
The human hippocampus and spatial and episodic memory. Neuron (2002) 6.09
Cellular bases of hippocampal EEG in the behaving rat. Brain Res (1983) 5.03
Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J Neurosci (2007) 4.34
Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology (2005) 4.09
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging (2003) 3.83
2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology (1999) 3.25
Synaptic plasticity, memory and the hippocampus: a neural network approach to causality. Nat Rev Neurosci (2008) 3.24
A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat Rev Neurosci (2011) 3.23
Pattern separation in the hippocampus. Trends Neurosci (2011) 3.21
Cellular mechanism of neuronal synchronization in epilepsy. Science (1982) 3.19
Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell (2012) 3.16
Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol (2009) 3.12
Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand Suppl (1996) 3.02
Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease. J Neurosci (2011) 2.96
Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron (2012) 2.89
Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model. Proc Natl Acad Sci U S A (2012) 2.84
FMRP mediates mGluR5-dependent translation of amyloid precursor protein. PLoS Biol (2007) 2.75
Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5. Neuron (2010) 2.34
Prolonged epileptiform discharges induced by altered group I metabotropic glutamate receptor-mediated synaptic responses in hippocampal slices of a fragile X mouse model. J Neurosci (2005) 2.34
Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. J Neurosci (2009) 2.33
BACE1 regulates voltage-gated sodium channels and neuronal activity. Nat Cell Biol (2007) 2.18
Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia (2006) 2.17
Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life. Arch Neurol (2005) 2.11
Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome. Neuron (2013) 2.00
Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene. J Neurol (2005) 1.94
Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein. Neuron (2013) 1.87
Phenotype associated with APP duplication in five families. Brain (2006) 1.83
Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome. Arch Pathol Lab Med (2001) 1.82
Requirement of protein synthesis for group I mGluR-mediated induction of epileptiform discharges. J Neurophysiol (1998) 1.80
Potassium conductances in hippocampal neurons blocked by excitatory amino-acid transmitters. Nature (1990) 1.77
Synchronized burst discharge in disinhibited hippocampal slice. I. Initiation in CA2-CA3 region. J Neurophysiol (1983) 1.72
Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2012) 1.58
A perfect storm: Converging paths of epilepsy and Alzheimer's dementia intersect in the hippocampal formation. Epilepsia (2011) 1.53
The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment. Neurosci Biobehav Rev (2000) 1.53
Internalized antibodies to the Abeta domain of APP reduce neuronal Abeta and protect against synaptic alterations. J Biol Chem (2007) 1.52
Dietary energy substrates reverse early neuronal hyperactivity in a mouse model of Alzheimer's disease. J Neurochem (2013) 1.51
Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2. Brain (2010) 1.45
Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease. Prog Brain Res (2002) 1.43
Auditory system degeneration in Alzheimer's disease. Neurology (1993) 1.39
Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease. Brain (2010) 1.35
Seizures in Alzheimer disease: who, when, and how common? Arch Neurol (2009) 1.34
SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5. J Pharmacol Exp Ther (1999) 1.31
Down syndrome, Alzheimer's disease and seizures. Brain Dev (2005) 1.29
Role of group I metabotropic glutamate receptors in the patterning of epileptiform activities in vitro. J Neurophysiol (1997) 1.26
Increased seizure threshold and severity in young transgenic CRND8 mice. Neurosci Lett (2004) 1.26
Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links. Neurology (2011) 1.20
Linking hippocampal structure and function to memory performance in an aging population. Arch Neurol (2009) 1.17
Reversal of fragile X phenotypes by manipulation of AβPP/Aβ levels in Fmr1KO mice. PLoS One (2011) 1.15
BC1 regulation of metabotropic glutamate receptor-mediated neuronal excitability. J Neurosci (2009) 1.14
Generation of the beta-amyloid peptide and the amyloid precursor protein C-terminal fragment gamma are potentiated by FE65L1. J Biol Chem (2003) 1.12
Genetic suppression of transgenic APP rescues Hypersynchronous network activity in a mouse model of Alzeimer's disease. J Neurosci (2014) 1.11
Epidemiological and medical aspects of epilepsy in the elderly. Epilepsy Res (2005) 1.09
Seizures and epilepsy in Alzheimer's disease. CNS Neurosci Ther (2011) 1.05
Animal models of epilepsy: use and limitations. Neuropsychiatr Dis Treat (2014) 1.04
Synchronized oscillations in hippocampal CA3 neurons induced by metabotropic glutamate receptor activation. J Neurosci (1995) 1.02
Role of synaptic metabotropic glutamate receptors in epileptiform discharges in hippocampal slices. J Neurophysiol (2002) 1.01
Staging of Alzheimer's pathology in triple transgenic mice: a light and electron microscopic analysis. Int J Alzheimers Dis (2010) 0.98
Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's disease. J Neurochem (2014) 0.98
Shared cognitive and behavioral impairments in epilepsy and Alzheimer's disease and potential underlying mechanisms. Epilepsy Behav (2013) 0.98
Human epileptic neurons studied in vitro. Brain Res (1981) 0.95
Pattern separation and pattern completion in Alzheimer's disease: evidence of rapid forgetting in amnestic mild cognitive impairment. Hippocampus (2013) 0.95
Alzheimer's disease and epilepsy: insight from animal models. Future Neurol (2012) 0.94
What's hAPPening at synapses? The role of amyloid β-protein precursor and β-amyloid in neurological disorders. Mol Psychiatry (2012) 0.93
Dual regulation of fragile X mental retardation protein by group I metabotropic glutamate receptors controls translation-dependent epileptogenesis in the hippocampus. J Neurosci (2011) 0.91
Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat Rev Neurosci (2016) 0.90
Sodium channel cleavage is associated with aberrant neuronal activity and cognitive deficits in a mouse model of Alzheimer's disease. J Neurosci (2013) 0.90
Alzheimer's disease and Down syndrome rodent models exhibit audiogenic seizures. J Alzheimers Dis (2010) 0.90
Increased hippocampal excitability in the 3xTgAD mouse model for Alzheimer's disease in vivo. PLoS One (2014) 0.89
Tau-dependent Kv4.2 depletion and dendritic hyperexcitability in a mouse model of Alzheimer's disease. J Neurosci (2015) 0.88
Synchronized burst discharge in disinhibited hippocampal slice. II. Model of cellular mechanism. J Neurophysiol (1983) 0.88
Characterizing the memory changes in persons with mild cognitive impairment. Prog Brain Res (2008) 0.88
Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies. J Neural Transm (Vienna) (2014) 0.87
Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance. Neuroimage Clin (2015) 0.87
MPEP reduces seizure severity in Fmr-1 KO mice over expressing human Abeta. Int J Clin Exp Pathol (2009) 0.87
Storm before the quiet: neuronal hyperactivity and Aβ in the presymptomatic stages of Alzheimer's disease. Neurobiol Aging (2014) 0.87
Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease. Neurobiol Dis (2014) 0.87
Does epileptiform activity contribute to cognitive impairment in Alzheimer's disease? Neuron (2007) 0.85
Different electrophysiological actions of 24- and 72-hour aggregated amyloid-beta oligomers on hippocampal field population spike in both anesthetized and awake rats. Brain Res (2010) 0.85
Entorhinal cortical defects in Tg2576 mice are present as early as 2-4 months of age. Neurobiol Aging (2014) 0.85
Seizures in Alzheimer's disease. Neuroscience (2014) 0.85
Intraneuronal Aβ accumulation induces hippocampal neuron hyperexcitability through A-type K(+) current inhibition mediated by activation of caspases and GSK-3. Neurobiol Aging (2014) 0.84
Transgenic mice as a model for Alzheimer's disease. Curr Alzheimer Res (2011) 0.84
Regulatory BC1 RNA and the fragile X mental retardation protein: convergent functionality in brain. PLoS One (2010) 0.84
"Untangling" Alzheimer's disease and epilepsy. Epilepsy Curr (2012) 0.83
Tau-mediated NMDA receptor impairment underlies dysfunction of a selectively vulnerable network in a mouse model of frontotemporal dementia. J Neurosci (2014) 0.82
Reference and working memory deficits in the 3xTg-AD mouse between 2 and 15-months of age: a cross-sectional study. Behav Brain Res (2014) 0.82
Persistent receptor activity underlies group I mGluR-mediated cellular plasticity in CA3 neuron. J Neurosci (2013) 0.81
Enhancement of neurogenesis and memory by a neurotrophic peptide in mild to moderate traumatic brain injury. Neurosurgery (2015) 0.81
Episodic-like memory is sensitive to both Alzheimer's-like pathological accumulation and normal ageing processes in mice. Behav Brain Res (2013) 0.81
Synaptic mechanisms underlying interictal spike initiation in a hippocampal network. Neurology (1983) 0.81
Hyperexcitability and epileptic seizures in a model of frontotemporal dementia. Neurobiol Dis (2013) 0.80